Madras Medical Mission,

Chennai 600037

0 studies enrolling now · 4 studies all time

What they study most

Heart Failure, Myocardial Infarction, Percutaneous Coronary Intervention, Stable Coronary Artery Disease

Studies at this site

• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy — Completed